An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and effectiveness of fluconazole as an intravenous dose as initial
treatment for acute cryptococcal meningitis followed by oral therapy in AIDS and non-AIDS
patients. Lack of satisfactory response will allow increase of dose. Both newly diagnosed and
relapsed patients are eligible.